Suministro del medicamento exclusivo: Ciltacabtagen autoleucel (CARVYKTI 3,2X10E6-1x10E8 células dispersión).
TED · 634782-2026Award noticeawardedNo deadline given
Buyer
NameServicio Madrileno de Salud, Hospital Universitario La Paz
CountryES
Published2026-09-15
Deadline—
Who already wins at this buyer
Firms with recorded awards from Servicio Madrileno de Salud, Hospital Universitario La Paz in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE FARMA, S.A.U. | 2 | €2,779,646 | 2026-06-15 |
| GILEAD SCIENCES, S.L. | 2 | €898,026 | 2026-09-04 |
| BRISTOL-MYERS SQUIBB, S.A.U. | 2 | €824,543 | 2026-06-29 |
| BIOGEN SPAIN, S.L. | 1 | €2,964,125 | 2026-09-15 |
| ALEXION PHARMA SPAIN S.L.U. | 1 | €2,603,216 | 2026-09-09 |
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Suministro del medicamento exclusivo: Ciltacabtagen autoleucel (CARVYKTI 3,2X10E6-1x10E8 células dispersión).